Trial initiation in S Korea rose by 150% from 2006-09

By Nick Taylor

- Last updated on GMT

Clinical trials initiated annually in South Korea increased by 150 per cent between 2006 and 2009. Outsourcing-Pharma presents this as part of a visualisation looking at the growth of clinical trials in Asia over the past decade.

India and China dominate discussions about clinical trials in Asia but, according to data from​, it is South Korea that has experienced the fastest growth in recent years. Between 2006 and 2009 the number of trials initiated annually increased from 206 to 513.

South Korea has benefited from the liberalisation of Japanese regulations regarding where clinical trial data is generated. The regulatory shift has driven demand for trials in China, Taiwan, and, as shown in the data, South Korea.

When the data is presented as number of clinical trials initiated per 1m people in the country Singapore is the dominant player in the region. Graphs can be filtered using the dropdown boxes to show data specific to a certain country or year.

Between 2004 and 2005 there is a large leap in the number of clinical trials initiated in all countries. This change is underpinned by a number of factors which are discussed here​.

Below is a heat map showing trials initiated each year per 1m population. Pressing the play button in t bottom left animates the map to show the changes between 2000 and 2009.

Related news

Show more

Related products


Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers